Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US House Member Has Questions On FDA’s Policy On NMN, Also Asks For Public Hearing

May 02 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

It’s Official: US Enforcement Discretion For NAC In Supplements, And Regulatory Options For FDA

Apr 21 2022

‘Unlawful Marketing’ Doesn't Establish Dietary Ingredients' Use Before Drug Approval Or Study

Mar 16 2023

Petition To US FDA For Using NMN In Supplements Reminds Agency Of Its Reversal On NAC

Mar 16 2023

Additional Topics

International United States US States Politics Dietary Supplements FDA Enforcement Business Strategies Commercial Compliance Consumer E-Commerce Ingredients Manufacturing Policy Regulation Safety

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window